What is the recommended acute management of variceal hemorrhage, including resuscitation targets, vasoactive agents, prophylactic antibiotics, timing of endoscopy, and rescue therapies?

Acute Management of Variceal Hemorrhage

Immediately initiate vasoactive agents (octreotide in the US: 50 mcg IV bolus, then 50 mcg/hr infusion) and IV ceftriaxone 1g daily as soon as variceal bleeding is suspected—before performing endoscopy—as this combination reduces mortality, infection, and rebleeding. 1

Initial Resuscitation and Hemodynamic Management

Target restrictive transfusion strategy with hemoglobin threshold of 70 g/L, aiming for post-transfusion hemoglobin of 70-90 g/L. This approach improves outcomes in hemodynamically stable patients without cardiovascular disease 2. Avoid over-resuscitation as it increases portal pressure and rebleeding risk.

Key Resuscitation Principles:

• Do NOT correct INR with FFP or factor VIIa—INR is unreliable in cirrhosis and correction shows no benefit 1, 3
• Do NOT use tranexamic acid—a large trial of 12,009 patients showed no benefit in variceal bleeding 3
• No specific recommendations exist for platelet transfusion 1

Pharmacologic Therapy (Start Immediately)

Vasoactive Agents

Begin vasoactive therapy immediately upon suspicion of variceal bleeding, before endoscopy, and continue for 2-5 days. These agents reduce 7-day mortality and transfusion requirements 1.

In the United States, use octreotide:

• Initial IV bolus: 50 mcg (can repeat in first hour if ongoing bleeding)
• Continuous infusion: 50 mcg/hr for 2-5 days 1

If available outside the US, terlipressin, somatostatin, and octreotide show similar efficacy, though terlipressin is the only agent proven to improve survival 4, 5.

Antibiotic Prophylaxis

Administer IV ceftriaxone 1g every 24 hours for up to 7 days maximum. Antibiotic prophylaxis decreases infections, rebleeding, and death 1.

Ceftriaxone is superior to norfloxacin (which is no longer available in the US) and is first-choice for:

• Advanced cirrhosis (Child-Pugh B/C)
• Patients already on quinolone prophylaxis
• Settings with high quinolone resistance 1

Tailor antibiotic choice to local resistance patterns and individual risk factors 1.

Pre-Endoscopy Preparation

Give IV erythromycin 250 mg 30-120 minutes before endoscopy to improve visualization by promoting gastric emptying 2.

Endoscopic Management

Perform upper endoscopy within 12 hours of presentation once hemodynamically stable. 1, 2

Endoscopic band ligation (EBL) is the treatment of choice for esophageal varices. 1, 2 Sclerotherapy is an alternative only if banding is technically impossible 4.

Diagnostic Criteria:

• Certain variceal hemorrhage: Active bleeding from varix or "white nipple" sign
• Inferred variceal hemorrhage: Varices are only lesion found with blood in stomach or endoscopy >24 hours after bleeding 1

Risk Stratification and Rescue Therapy

High-Risk Patients Requiring Early TIPS

Consider pre-emptive TIPS within 72 hours (preferably within 24 hours) for high-risk patients:

• Child-Pugh C score 10-13, OR
• Child-Pugh B with active bleeding at endoscopy despite vasoactive drugs, OR
• HVPG >20 mmHg 1, 2

This strategy significantly reduces treatment failure and mortality in carefully selected patients using covered TIPS stents 1.

Treatment Failure (10-20% of cases)

If bleeding persists despite vasoactive drugs and endoscopic therapy, proceed to urgent rescue TIPS. 2, 4

Balloon tamponade or covered esophageal stents serve only as temporary bridge to definitive therapy (TIPS) in unstable patients 6, 4.

Gastric Varices (Special Consideration)

• GOV2 and IGV1: Cyanoacrylate injection is treatment of choice 2
• GOV1: Either cyanoacrylate injection or EBL 2
• Failure of endoscopic hemostasis: Consider rescue TIPS or balloon-occluded retrograde transvenous obliteration (BRTO) 2

Common Pitfalls to Avoid

1. Delaying vasoactive agents and antibiotics until after endoscopy—these must start immediately upon suspicion
2. Over-transfusing—target Hgb 70-90 g/L, not higher
3. Correcting INR—wastes resources and provides no benefit
4. Using tranexamic acid—no evidence of benefit in variceal bleeding
5. Waiting too long for TIPS in high-risk patients—early pre-emptive TIPS (within 24-72 hours) dramatically improves survival in Child-Pugh B with active bleeding or Child-Pugh C 10-13

Secondary Prevention

After successful hemostasis, schedule follow-up EBL at 1-4 week intervals until variceal eradication, then surveillance every 3-6 months in the first year 2. Combine with non-selective beta blockers (propranolol or carvedilol) for optimal secondary prophylaxis 2.